110 IRVING ST NW, Washington, DC
Contact for insurance details
110 IRVING ST NW, Washington, DC
Contact for insurance details
50 IRVING ST NW, Washington, DC
Contact for insurance details
2041 GEORGIA AVE NW, Washington, DC
Contact for insurance details
1200 G ST NW STE 800, Washington, DC
Contact for insurance details
3 WASHINGTON CIR NW, Washington, DC
Contact for insurance details
2150 PENNSYLVANIA AVE NW, Washington, DC
Contact for insurance details
1160 VARNUM ST NE, Washington, DC
Contact for insurance details
700 2ND ST NE, Washington, DC
Contact for insurance details
3800 RESERVOIR RD NW, Washington, DC
Contact for insurance details
## GLP-1 Weight Loss Clinics in Washington, DC Washington is home to 68 GLP-1 weight loss providers, including endocrinologists, obesity medicine specialists, internal medicine physicians, and weight management clinics. The Washington-Arlington-Alexandria metropolitan area has an adult obesity rate of 24.7%, and demand for GLP-1 medications like semaglutide (Wegovy) and tirzepatide (Zepbound) continues to grow. ## Finding the Right Provider When choosing a GLP-1 provider in Washington, look for board-certified physicians with experience in obesity medicine or endocrinology. Qualified providers conduct thorough medical evaluations before prescribing, offer ongoing monitoring during dose titration, and provide nutritional counseling alongside medication. Our directory lists providers with verified NPI credentials, so you can confirm their licensure and specialty before scheduling an appointment. ## Insurance and Cost District of Columbia Medicaid does not currently cover GLP-1 medications for obesity. Patients without commercial insurance coverage can access manufacturer discount programs, including LillyDirect Zepbound vials at $299 to $449 per month and NovoCare Wegovy at $499 per month. For commercially insured patients, most major carriers in District of Columbia now cover at least one GLP-1 medication for weight management with prior authorization. Manufacturer savings cards can reduce copays to $0 to $25 per month for eligible patients. Oral Wegovy, the newest formulation approved in December 2025, is available at $149 to $299 per month through select pharmacies, offering a lower-cost alternative to injectable options. ## Telehealth Options DC permits telehealth prescribing by providers licensed in the District. Providers licensed in Maryland or Virginia may also treat DC residents under interstate telehealth agreements. Many providers in Washington now offer both in-person and telehealth consultations, giving patients flexibility in how they access care. Telehealth can be particularly convenient for monthly follow-up visits during GLP-1 treatment.
Our directory lists 68 GLP-1 providers in Washington, DC, including endocrinologists, obesity medicine specialists, and weight management clinics. This count is based on NPI Registry data and is updated regularly.
No. District of Columbia Medicaid does not currently cover GLP-1 medications for obesity. Coverage is limited to diabetes indications. Cash-pay options include LillyDirect Zepbound vials ($299 to $449 per month) and NovoCare Wegovy ($499 per month).
Yes. District of Columbia permits telehealth prescribing of GLP-1 medications by state-licensed providers. Many clinics in Washington offer both in-person and virtual consultations.
Costs vary by medication and insurance status. With commercial insurance and a manufacturer savings card, copays typically range from $0 to $50 per month. Without insurance, options include oral Wegovy ($149 to $299 per month), LillyDirect Zepbound vials ($299 to $449 per month), and NovoCare Wegovy ($499 per month).
Look for board-certified providers in obesity medicine (ABOM), endocrinology, or internal medicine. Verify their NPI credentials, ask about their experience with GLP-1 prescribing, and confirm they offer ongoing monitoring and nutritional support alongside medication.
DC permits telehealth prescribing by providers licensed in the District. Providers licensed in Maryland or Virginia may also treat DC residents under interstate telehealth agreements.
Medical Disclaimer
The information on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. Individual results may vary.